Literature DB >> 7092253

Chronic cutaneous lupus erythematosus. Clinical, laboratory, therapeutic, and prognostic examination of 62 patients.

J P Callen.   

Abstract

Chronic discoid lupus erythematosus (DLE) is a common condition. Sixty-two patients with biopsy-proved, active DLE were observed and their conditions were analyzed for clinical, laboratory, and therapeutic data. Fifty-six patients had disease limited to the skin-26 localized and 30 widespread (above and below the neck). At the time of follow-up examination, active disease was present in 32 patients, 28 of whom had widespread DLE. Six patients had DLE as a manifestation of systemic LE (SLE). In four patients, the DLE preceded the development of SLE. Laboratory abnormalities were substantially more common in patients with widespread DLE than in patients with localized DLE. An analysis of therapeutic results in this series confirmed the beneficial effects of intralesional corticosteroids and antimalarial agents and demonstrated relatively poor responsiveness to topical or oral corticosteroids.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7092253     DOI: 10.1001/archderm.118.6.412

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  22 in total

1.  Cutaneous lupus and the Cutaneous Lupus Erythematosus Disease Area and Severity Index instrument.

Authors:  Rachel S Klein; Pamela A Morganroth; Victoria P Werth
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

2.  Association of discoid lupus erythematosus with other clinical manifestations among patients with systemic lupus erythematosus.

Authors:  Joseph F Merola; Stephen D Prystowsky; Christina Iversen; Jose A Gomez-Puerta; Tabatha Norton; Peter Tsao; Elena Massarotti; Peter Schur; Bonnie Bermas; Karen H Costenbader
Journal:  J Am Acad Dermatol       Date:  2013-03-28       Impact factor: 11.527

3.  Autoantibodies to evolutionarily conserved epitopes of enolase in a patient with discoid lupus erythematosus.

Authors:  V M Gitlits; J W Sentry; M L Matthew; A I Smith; B H Toh
Journal:  Immunology       Date:  1997-11       Impact factor: 7.397

4.  Response to antimalarial agents in cutaneous lupus erythematosus: a prospective analysis.

Authors:  Aileen Y Chang; Evan W Piette; Kristen P Foering; Thomas R Tenhave; Joyce Okawa; Victoria P Werth
Journal:  Arch Dermatol       Date:  2011-07-18

5.  A multicentre, cross-sectional study on quality of life in patients with cutaneous lupus erythematosus.

Authors:  R Vasquez; D Wang; Q P Tran; B Adams-Huet; M-M Chren; M I Costner; J B Cohen; V P Werth; B F Chong
Journal:  Br J Dermatol       Date:  2012-09-13       Impact factor: 9.302

6.  Prevalence of self-report photosensitivity in cutaneous lupus erythematosus.

Authors:  Kristen Foering; Renato Goreshi; Rachel Klein; Joyce Okawa; Mathew Rose; Andrew Cucchiara; Victoria P Werth
Journal:  J Am Acad Dermatol       Date:  2011-07-13       Impact factor: 11.527

7.  Recognising photosensitivity.

Authors:  C R Taylor; J L Hawk
Journal:  Ann Rheum Dis       Date:  1994-11       Impact factor: 19.103

Review 8.  Drugs for discoid lupus erythematosus.

Authors:  Sue Jessop; David A Whitelaw; Matthew J Grainge; Prativa Jayasekera
Journal:  Cochrane Database Syst Rev       Date:  2017-05-05

9.  Changes in T cell and B cell composition in discoid lupus erythematosus skin at different stages.

Authors:  Jack C O'Brien; Gregory A Hosler; Benjamin F Chong
Journal:  J Dermatol Sci       Date:  2016-12-05       Impact factor: 4.563

10.  Cross-sectional analysis of a collaborative Web-based database for lupus erythematosus-associated skin lesions: prospective enrollment of 114 patients.

Authors:  Siamak Moghadam-Kia; Katherine Chilek; Elizabeth Gaines; Melissa Costner; Mathew E Rose; Joyce Okawa; Victoria P Werth
Journal:  Arch Dermatol       Date:  2009-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.